← 治験一覧に戻る
非小細胞肺癌患者の手術後の併用化学療法と無治療との比較
基本情報
- NCT ID
- NCT00002823
- ステータス
- 完了
- 試験のフェーズ
- 第3相
- 試験タイプ
- 介入
- 目標被験者数
- 3,300
- 治験依頼者名
- Gustave Roussy, Cancer Campus, Grand Paris
概要
RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. It is not yet known if combination chemotherapy given after surgery is more effective than surgery alone for non-small cell lung cancer. PURPOSE: Randomized phase III trial to compare the effectiveness of combination chemotherapy following surgery with that of surgery alone in treating patients who have stage I, stage II, or stage IIIA non-small cell lung cancer.
対象疾患
Lung Cancer
介入
cisplatin(DRUG)
etoposide(DRUG)
vinblastine sulfate(DRUG)
vindesine(DRUG)
vinorelbine tartrate(DRUG)
radiation therapy(RADIATION)
依頼者(Sponsor)
実施施設 (1)
公立学校共済組合近畿中央病院
Osaka, Japan